1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Covid-19 Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Life Support 1.2.3 Antiviral Medicine 1.2.4 Antibody Treatments 1.2.5 Others 1.3 Market by Application 1.3.1 Global Covid-19 Treatment Market Share by End User: 2016 VS 2021 VS 2027 1.3.2 Children 1.3.3 Adult 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Covid-19 Treatment Market Perspective (2016-2027) 2.2 Covid-19 Treatment Growth Trends by Regions 2.2.1 Covid-19 Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Covid-19 Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Covid-19 Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Covid-19 Treatment Industry Dynamic 2.3.1 Covid-19 Treatment Market Trends 2.3.2 Covid-19 Treatment Market Drivers 2.3.3 Covid-19 Treatment Market Challenges 2.3.4 Covid-19 Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Covid-19 Treatment Players by Revenue 3.1.1 Global Top Covid-19 Treatment Players by Revenue (2016-2021) 3.1.2 Global Covid-19 Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Covid-19 Treatment Revenue 3.4 Global Covid-19 Treatment Market Concentration Ratio 3.4.1 Global Covid-19 Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Treatment Revenue in 2020 3.5 Covid-19 Treatment Key Players Head office and Area Served 3.6 Key Players Covid-19 Treatment Product Solution and Service 3.7 Date of Enter into Covid-19 Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Covid-19 Treatment Breakdown Data by Type 4.1 Global Covid-19 Treatment Historic Market Size by Type (2016-2021) 4.2 Global Covid-19 Treatment Forecasted Market Size by Type (2022-2027) 5 Covid-19 Treatment Breakdown Data by End User 5.1 Global Covid-19 Treatment Historic Market Size by End User (2016-2021) 5.2 Global Covid-19 Treatment Forecasted Market Size by End User (2022-2027) 6 North America 6.1 North America Covid-19 Treatment Market Size (2016-2027) 6.2 North America Covid-19 Treatment Market Size by Type 6.2.1 North America Covid-19 Treatment Market Size by Type (2016-2021) 6.2.2 North America Covid-19 Treatment Market Size by Type (2022-2027) 6.2.3 North America Covid-19 Treatment Market Size by Type (2016-2027) 6.3 North America Covid-19 Treatment Market Size by End User 6.3.1 North America Covid-19 Treatment Market Size by End User (2016-2021) 6.3.2 North America Covid-19 Treatment Market Size by End User (2022-2027) 6.3.3 North America Covid-19 Treatment Market Size by End User (2016-2027) 6.4 North America Covid-19 Treatment Market Size by Country 6.4.1 North America Covid-19 Treatment Market Size by Country (2016-2021) 6.4.2 North America Covid-19 Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Covid-19 Treatment Market Size (2016-2027) 7.2 Europe Covid-19 Treatment Market Size by Type 7.2.1 Europe Covid-19 Treatment Market Size by Type (2016-2021) 7.2.2 Europe Covid-19 Treatment Market Size by Type (2022-2027) 7.2.3 Europe Covid-19 Treatment Market Size by Type (2016-2027) 7.3 Europe Covid-19 Treatment Market Size by End User 7.3.1 Europe Covid-19 Treatment Market Size by End User (2016-2021) 7.3.2 Europe Covid-19 Treatment Market Size by End User (2022-2027) 7.3.3 Europe Covid-19 Treatment Market Size by End User (2016-2027) 7.4 Europe Covid-19 Treatment Market Size by Country 7.4.1 Europe Covid-19 Treatment Market Size by Country (2016-2021) 7.4.2 Europe Covid-19 Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Covid-19 Treatment Market Size (2016-2027) 8.2 Asia-Pacific Covid-19 Treatment Market Size by Type 8.2.1 Asia-Pacific Covid-19 Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Covid-19 Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Covid-19 Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Covid-19 Treatment Market Size by End User 8.3.1 Asia-Pacific Covid-19 Treatment Market Size by End User (2016-2021) 8.3.2 Asia-Pacific Covid-19 Treatment Market Size by End User (2022-2027) 8.3.3 Asia-Pacific Covid-19 Treatment Market Size by End User (2016-2027) 8.4 Asia-Pacific Covid-19 Treatment Market Size by Region 8.4.1 Asia-Pacific Covid-19 Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Covid-19 Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Covid-19 Treatment Market Size (2016-2027) 9.2 Latin America Covid-19 Treatment Market Size by Type 9.2.1 Latin America Covid-19 Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Covid-19 Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Covid-19 Treatment Market Size by Type (2016-2027) 9.3 Latin America Covid-19 Treatment Market Size by End User 9.3.1 Latin America Covid-19 Treatment Market Size by End User (2016-2021) 9.3.2 Latin America Covid-19 Treatment Market Size by End User (2022-2027) 9.3.3 Latin America Covid-19 Treatment Market Size by End User (2016-2027) 9.4 Latin America Covid-19 Treatment Market Size by Country 9.4.1 Latin America Covid-19 Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Covid-19 Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Covid-19 Treatment Market Size (2016-2027) 10.2 Middle East & Africa Covid-19 Treatment Market Size by Type 10.2.1 Middle East & Africa Covid-19 Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Covid-19 Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Covid-19 Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Covid-19 Treatment Market Size by End User 10.3.1 Middle East & Africa Covid-19 Treatment Market Size by End User (2016-2021) 10.3.2 Middle East & Africa Covid-19 Treatment Market Size by End User (2022-2027) 10.3.3 Middle East & Africa Covid-19 Treatment Market Size by End User (2016-2027) 10.4 Middle East & Africa Covid-19 Treatment Market Size by Country 10.4.1 Middle East & Africa Covid-19 Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Covid-19 Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Cadila Healthcare 11.1.1 Cadila Healthcare Company Details 11.1.2 Cadila Healthcare Business Overview 11.1.3 Cadila Healthcare Covid-19 Treatment Introduction 11.1.4 Cadila Healthcare Revenue in Covid-19 Treatment Business (2016-2021) 11.1.5 Cadila Healthcare Recent Development 11.2 Johnson & Johnson 11.2.1 Johnson & Johnson Company Details 11.2.2 Johnson & Johnson Business Overview 11.2.3 Johnson & Johnson Covid-19 Treatment Introduction 11.2.4 Johnson & Johnson Revenue in Covid-19 Treatment Business (2016-2021) 11.2.5 Johnson & Johnson Recent Development 11.3 ImmunoPrecise 11.3.1 ImmunoPrecise Company Details 11.3.2 ImmunoPrecise Business Overview 11.3.3 ImmunoPrecise Covid-19 Treatment Introduction 11.3.4 ImmunoPrecise Revenue in Covid-19 Treatment Business (2016-2021) 11.3.5 ImmunoPrecise Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Covid-19 Treatment Introduction 11.4.4 Novartis Revenue in Covid-19 Treatment Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 AstraZeneca 11.5.1 AstraZeneca Company Details 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca Covid-19 Treatment Introduction 11.5.4 AstraZeneca Revenue in Covid-19 Treatment Business (2016-2021) 11.5.5 AstraZeneca Recent Development 11.6 Cipla 11.6.1 Cipla Company Details 11.6.2 Cipla Business Overview 11.6.3 Cipla Covid-19 Treatment Introduction 11.6.4 Cipla Revenue in Covid-19 Treatment Business (2016-2021) 11.6.5 Cipla Recent Development 11.7 AbbVie 11.7.1 AbbVie Company Details 11.7.2 AbbVie Business Overview 11.7.3 AbbVie Covid-19 Treatment Introduction 11.7.4 AbbVie Revenue in Covid-19 Treatment Business (2016-2021) 11.7.5 AbbVie Recent Development 11.8 Bayer 11.8.1 Bayer Company Details 11.8.2 Bayer Business Overview 11.8.3 Bayer Covid-19 Treatment Introduction 11.8.4 Bayer Revenue in Covid-19 Treatment Business (2016-2021) 11.8.5 Bayer Recent Development 11.9 Regeneron Pharmaceuticals 11.9.1 Regeneron Pharmaceuticals Company Details 11.9.2 Regeneron Pharmaceuticals Business Overview 11.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Introduction 11.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Treatment Business (2016-2021) 11.9.5 Regeneron Pharmaceuticals Recent Development 11.10 Ascletis Pharma 11.10.1 Ascletis Pharma Company Details 11.10.2 Ascletis Pharma Business Overview 11.10.3 Ascletis Pharma Covid-19 Treatment Introduction 11.10.4 Ascletis Pharma Revenue in Covid-19 Treatment Business (2016-2021) 11.10.5 Ascletis Pharma Recent Development 11.11 GlaxoSmithKline 11.11.1 GlaxoSmithKline Company Details 11.11.2 GlaxoSmithKline Business Overview 11.11.3 GlaxoSmithKline Covid-19 Treatment Introduction 11.11.4 GlaxoSmithKline Revenue in Covid-19 Treatment Business (2016-2021) 11.11.5 GlaxoSmithKline Recent Development 11.12 Gilead Sciences 11.12.1 Gilead Sciences Company Details 11.12.2 Gilead Sciences Business Overview 11.12.3 Gilead Sciences Covid-19 Treatment Introduction 11.12.4 Gilead Sciences Revenue in Covid-19 Treatment Business (2016-2021) 11.12.5 Gilead Sciences Recent Development 11.13 Pharmstandard 11.13.1 Pharmstandard Company Details 11.13.2 Pharmstandard Business Overview 11.13.3 Pharmstandard Covid-19 Treatment Introduction 11.13.4 Pharmstandard Revenue in Covid-19 Treatment Business (2016-2021) 11.13.5 Pharmstandard Recent Development 11.14 Fujifilm Holdings 11.14.1 Fujifilm Holdings Company Details 11.14.2 Fujifilm Holdings Business Overview 11.14.3 Fujifilm Holdings Covid-19 Treatment Introduction 11.14.4 Fujifilm Holdings Revenue in Covid-19 Treatment Business (2016-2021) 11.14.5 Fujifilm Holdings Recent Development 11.15 Zhejiang Hisun Pharmaceutical Co. Ltd 11.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details 11.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview 11.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Introduction 11.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Treatment Business (2016-2021) 11.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development 11.16 Roche 11.16.1 Roche Company Details 11.16.2 Roche Business Overview 11.16.3 Roche Covid-19 Treatment Introduction 11.16.4 Roche Revenue in Covid-19 Treatment Business (2016-2021) 11.16.5 Roche Recent Development 11.17 Sanofi 11.17.1 Sanofi Company Details 11.17.2 Sanofi Business Overview 11.17.3 Sanofi Covid-19 Treatment Introduction 11.17.4 Sanofi Revenue in Covid-19 Treatment Business (2016-2021) 11.17.5 Sanofi Recent Development 11.18 Pfizer 11.18.1 Pfizer Company Details 11.18.2 Pfizer Business Overview 11.18.3 Pfizer Covid-19 Treatment Introduction 11.18.4 Pfizer Revenue in Covid-19 Treatment Business (2016-2021) 11.18.5 Pfizer Recent Development 11.19 Eli Lilly 11.19.1 Eli Lilly Company Details 11.19.2 Eli Lilly Business Overview 11.19.3 Eli Lilly Covid-19 Treatment Introduction 11.19.4 Eli Lilly Revenue in Covid-19 Treatment Business (2016-2021) 11.19.5 Eli Lilly Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Covid-19 Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Life Support Table 3. Key Players of Antiviral Medicine Table 4. Key Players of Antibody Treatments Table 5. Key Players of Others Table 6. Global Covid-19 Treatment Market Size Growth by End User (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Covid-19 Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Covid-19 Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Covid-19 Treatment Market Share by Regions (2016-2021) Table 10. Global Covid-19 Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Covid-19 Treatment Market Share by Regions (2022-2027) Table 12. Covid-19 Treatment Market Trends Table 13. Covid-19 Treatment Market Drivers Table 14. Covid-19 Treatment Market Challenges Table 15. Covid-19 Treatment Market Restraints Table 16. Global Covid-19 Treatment Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Covid-19 Treatment Market Share by Players (2016-2021) Table 18. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatment as of 2020) Table 19. Ranking of Global Top Covid-19 Treatment Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Covid-19 Treatment Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Covid-19 Treatment Product Solution and Service Table 23. Date of Enter into Covid-19 Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million) Table 26. Global Covid-19 Treatment Revenue Market Share by Type (2016-2021) Table 27. Global Covid-19 Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Covid-19 Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Covid-19 Treatment Market Size Share by End User (2016-2021) & (US$ Million) Table 30. Global Covid-19 Treatment Revenue Market Share by End User (2016-2021) Table 31. Global Covid-19 Treatment Forecasted Market Size by End User (2022-2027) (US$ Million) Table 32. Global Covid-19 Treatment Revenue Market Share by End User (2022-2027) & (US$ Million) Table 33. North America Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million) Table 34. North America Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Covid-19 Treatment Market Size by End User (2016-2021) (US$ Million) Table 36. North America Covid-19 Treatment Market Size by End User (2022-2027) & (US$ Million) Table 37. North America Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Covid-19 Treatment Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Covid-19 Treatment Market Size by End User (2016-2021) (US$ Million) Table 42. Europe Covid-19 Treatment Market Size by End User (2022-2027) & (US$ Million) Table 43. Europe Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Covid-19 Treatment Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Covid-19 Treatment Market Size by End User (2016-2021) (US$ Million) Table 48. Asia-Pacific Covid-19 Treatment Market Size by End User (2022-2027) & (US$ Million) Table 49. Asia-Pacific Covid-19 Treatment Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Covid-19 Treatment Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Covid-19 Treatment Market Size by End User (2016-2021) (US$ Million) Table 54. Latin America Covid-19 Treatment Market Size by End User (2022-2027) & (US$ Million) Table 55. Latin America Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Covid-19 Treatment Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Covid-19 Treatment Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Covid-19 Treatment Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Covid-19 Treatment Market Size by End User (2016-2021) (US$ Million) Table 60. Middle East & Africa Covid-19 Treatment Market Size by End User (2022-2027) & (US$ Million) Table 61. Middle East & Africa Covid-19 Treatment Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Covid-19 Treatment Market Size by Country (2022-2027) & (US$ Million) Table 63. Cadila Healthcare Company Details Table 64. Cadila Healthcare Business Overview Table 65. Cadila Healthcare Covid-19 Treatment Product Table 66. Cadila Healthcare Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 67. Cadila Healthcare Recent Development Table 68. Johnson & Johnson Company Details Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Covid-19 Treatment Product Table 71. Johnson & Johnson Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 72. Johnson & Johnson Recent Development Table 73. ImmunoPrecise Company Details Table 74. ImmunoPrecise Business Overview Table 75. ImmunoPrecise Covid-19 Treatment Product Table 76. ImmunoPrecise Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 77. ImmunoPrecise Recent Development Table 78. Novartis Company Details Table 79. Novartis Business Overview Table 80. Novartis Covid-19 Treatment Product Table 81. Novartis Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 82. Novartis Recent Development Table 83. AstraZeneca Company Details Table 84. AstraZeneca Business Overview Table 85. AstraZeneca Covid-19 Treatment Product Table 86. AstraZeneca Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 87. AstraZeneca Recent Development Table 88. Cipla Company Details Table 89. Cipla Business Overview Table 90. Cipla Covid-19 Treatment Product Table 91. Cipla Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 92. Cipla Recent Development Table 93. AbbVie Company Details Table 94. AbbVie Business Overview Table 95. AbbVie Covid-19 Treatment Product Table 96. AbbVie Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 97. AbbVie Recent Development Table 98. Bayer Company Details Table 99. Bayer Business Overview Table 100. Bayer Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 101. Bayer Recent Development Table 102. Regeneron Pharmaceuticals Company Details Table 103. Regeneron Pharmaceuticals Business Overview Table 104. Regeneron Pharmaceuticals Covid-19 Treatment Product Table 105. Regeneron Pharmaceuticals Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 106. Regeneron Pharmaceuticals Recent Development Table 107. Ascletis Pharma Company Details Table 108. Ascletis Pharma Business Overview Table 109. Ascletis Pharma Covid-19 Treatment Product Table 110. Ascletis Pharma Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 111. Ascletis Pharma Recent Development Table 112. GlaxoSmithKline Company Details Table 113. GlaxoSmithKline Business Overview Table 114. GlaxoSmithKline Covid-19 Treatment Product Table 115. GlaxoSmithKline Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 116. GlaxoSmithKline Recent Development Table 117. Gilead Sciences Company Details Table 118. Gilead Sciences Business Overview Table 119. Gilead Sciences Covid-19 Treatment Product Table 120. Gilead Sciences Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 121. Gilead Sciences Recent Development Table 122. Pharmstandard Company Details Table 123. Pharmstandard Business Overview Table 124. Pharmstandard Covid-19 Treatment Product Table 125. Pharmstandard Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 126. Pharmstandard Recent Development Table 127. Fujifilm Holdings Company Details Table 128. Fujifilm Holdings Business Overview Table 129. Fujifilm Holdings Covid-19 Treatment Product Table 130. Fujifilm Holdings Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 131. Fujifilm Holdings Recent Development Table 132. Zhejiang Hisun Pharmaceutical Co. Ltd Company Details Table 133. Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview Table 134. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product Table 135. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 136. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development Table 137. Roche Company Details Table 138. Roche Business Overview Table 139. Roche Covid-19 Treatment Product Table 140. Roche Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 141. Roche Recent Development Table 142. Sanofi Company Details Table 143. Sanofi Business Overview Table 144. Sanofi Covid-19 Treatment Product Table 145. Sanofi Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 146. Sanofi Recent Development Table 147. Pfizer Company Details Table 148. Pfizer Business Overview Table 149. Pfizer Covid-19 Treatment Product Table 150. Pfizer Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 151. Pfizer Recent Development Table 152. Eli Lilly Company Details Table 153. Eli Lilly Business Overview Table 154. Eli Lilly Covid-19 Treatment Product Table 155. Eli Lilly Revenue in Covid-19 Treatment Business (2016-2021) & (US$ Million) Table 156. Eli Lilly Recent Development Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Global Covid-19 Treatment Market Share by Type: 2020 VS 2027 Figure 2. Life Support Features Figure 3. Antiviral Medicine Features Figure 4. Antibody Treatments Features Figure 5. Others Features Figure 6. Global Covid-19 Treatment Market Share by End User: 2020 VS 2027 Figure 7. Children Case Studies Figure 8. Adult Case Studies Figure 9. Covid-19 Treatment Report Years Considered Figure 10. Global Covid-19 Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Covid-19 Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Covid-19 Treatment Market Share by Regions: 2020 VS 2027 Figure 13. Global Covid-19 Treatment Market Share by Regions (2022-2027) Figure 14. Global Covid-19 Treatment Market Share by Players in 2020 Figure 15. Global Top Covid-19 Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatment as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Covid-19 Treatment Revenue in 2020 Figure 17. Global Covid-19 Treatment Revenue Market Share by Type (2016-2021) Figure 18. Global Covid-19 Treatment Revenue Market Share by Type (2022-2027) Figure 19. North America Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Covid-19 Treatment Market Share by Type (2016-2027) Figure 21. North America Covid-19 Treatment Market Share by End User (2016-2027) Figure 22. North America Covid-19 Treatment Market Share by Country (2016-2027) Figure 23. United States Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Covid-19 Treatment Market Share by Type (2016-2027) Figure 27. Europe Covid-19 Treatment Market Share by End User (2016-2027) Figure 28. Europe Covid-19 Treatment Market Share by Country (2016-2027) Figure 29. Germany Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Covid-19 Treatment Market Share by Type (2016-2027) Figure 37. Asia-Pacific Covid-19 Treatment Market Share by End User (2016-2027) Figure 38. Asia-Pacific Covid-19 Treatment Market Share by Region (2016-2027) Figure 39. China Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Covid-19 Treatment Market Share by Type (2016-2027) Figure 47. Latin America Covid-19 Treatment Market Share by End User (2016-2027) Figure 48. Latin America Covid-19 Treatment Market Share by Country (2016-2027) Figure 49. Mexico Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Covid-19 Treatment Market Share by Type (2016-2027) Figure 53. Middle East & Africa Covid-19 Treatment Market Share by End User (2016-2027) Figure 54. Middle East & Africa Covid-19 Treatment Market Share by Country (2016-2027) Figure 55. Turkey Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Covid-19 Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Cadila Healthcare Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 59. Johnson & Johnson Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 60. ImmunoPrecise Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 61. Novartis Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 62. AstraZeneca Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 63. Cipla Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 64. AbbVie Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 65. Bayer Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 66. Regeneron Pharmaceuticals Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 67. Ascletis Pharma Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 68. GlaxoSmithKline Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 69. Gilead Sciences Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 70. Pharmstandard Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 71. Fujifilm Holdings Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 72. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 73. Roche Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 74. Sanofi Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 75. Pfizer Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 76. Eli Lilly Revenue Growth Rate in Covid-19 Treatment Business (2016-2021) Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

Cadila Healthcare Johnson & Johnson ImmunoPrecise Novartis AstraZeneca Cipla AbbVie Bayer Regeneron Pharmaceuticals Ascletis Pharma GlaxoSmithKline Gilead Sciences Pharmstandard Fujifilm Holdings Zhejiang Hisun Pharmaceutical Co. Ltd Roche Sanofi Pfizer Eli Lilly